Digital biopsy score may predict liver failure risk in fatty liver patients
NCT ID NCT06493253
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a computer analysis of liver biopsy images (called FibroNest Ph-FCS) can predict future liver complications in people with a type of fatty liver disease called MASLD. Researchers reviewed medical records from 1,578 patients to see if the digital score was better at forecasting liver-related events than standard methods. No new treatments were tested; the goal was to confirm the test's accuracy as a prognostic tool.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Virginia Commonwealth University
Richmond, Virginia, 23284, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sleep apnea may signal hidden liver trouble
- Could a weekly shot help more people donate part of their liver?
- Could a diabetes drug turn back the biological clock in HIV?
- Fatty liver may be a hidden driver of heart attacks in diabetes
- Experimental drug aims to reverse liver scarring in MASH cirrhosis
- Weight-Loss drugs may offer early liver protection, study suggests